Research Podcast | Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering President and CEO Craig B. Thompson encourages high school students to pursue careers in science and introduces three speakers who discuss their inspiration for engaging in cancer research.

Leukemia expert Omar Abdel-Wahab says new therapies that reverse epigenetics — chemical changes within cells that drive gene expression — are being combined with conventional chemotherapy drugs to silence cancer-causing genes and treat some cancers.

Cell biologist Emily Foley says that research to understand how chromosomes are distributed during cell division has led to the development of anticancer drugs that prevent errors in this process and ensure genetic stability in cells.

Oncologist and cancer biologist Richard White explains how his research with genetically modified zebrafish, which reproduce quickly and are optically transparent, has shed light on how melanoma and other cancers spread.

Memorial Sloan Kettering President and CEO Craig Thompson along with neuropathologist Jason Huse and immunologist Morgan Huse explain how recent developments contribute to better treatments for cancer patients.

Immunologist Morgan Huse discusses how the orientation of T cells — a type of white blood cell — affects the way they mount an immune response.

Neuropathologist Jason Huse discusses personalized medicine and how studying the molecular pathology of patients’ tumors can lead to new therapies.

Memorial Sloan Kettering President and CEO Craig B. Thompson welcomes attendees to the seventh annual Major Trends in Modern Cancer Research lecture for high school students and introduces the speakers.

Oncologist and cancer biologist Richard White explains how his research with genetically modified zebrafish, which reproduce quickly and are optically transparent, has shed light on how melanoma and other cancers spread.

Memorial Sloan Kettering President and CEO Craig Thompson along with cancer biologist Andrea Ventura, molecular biologist Iestyn Whitehouse, and developmental biologist Jennifer Zallen explain how recent developments contribute to better treatments for cancer patients.